BSX - Boston Scientific Corp.
Close
81.79
1.120 1.369%
Share volume: 7,629,333
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$80.67
1.12
1.39%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-01 | 2024-02-20 | 2024-05-01 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 31.947 B | 32.469 B | 32.891 B | 33.603 B | 34.043 B | 35.134 B | 36.669 B | 37.110 B | |
| Current Assets | 5.143 B | 5.760 B | 5.703 B | 5.888 B | 6.506 B | 6.513 B | 8.184 B | 8.992 B | |
| Inventories | 1.788 B | 1.867 B | 2.050 B | 2.250 B | 2.405 B | 2.484 B | 2.561 B | 2.608 B | |
| Other Current Assets | 1.034 B | 846.000 M | 872.000 M | 943.000 M | 925.000 M | 806.000 M | 897.000 M | 996.000 M | |
| Short Term Investments | 1.034 B | 846.000 M | 872.000 M | 943.000 M | 925.000 M | 806.000 M | 897.000 M | 996.000 M | |
| Total Receivables | 1.871 B | 1.970 B | 2.076 B | 2.134 B | 2.101 B | 2.228 B | 2.304 B | 2.400 B | |
| Current Cash | 338.000 M | 928.000 M | 570.000 M | 426.000 M | 952.000 M | 865.000 M | 2.329 B | 2.913 B | |
| Total Non-current Assets | 26.804 B | 26.709 B | 27.188 B | 27.715 B | 27.537 B | 28.621 B | 28.485 B | 28.118 B | |
| Property Plant Equipment | 2.273 B | 2.446 B | 2.478 B | 2.534 B | 2.635 B | 2.859 B | 2.897 B | 2.951 B | |
| Other Assets | 778.000 M | 659.000 M | 640.000 M | 668.000 M | 674.000 M | 619.000 M | 663.000 M | 612.000 M | |
| Intangible Assets | 6.058 B | 5.902 B | 6.060 B | 6.063 B | 5.849 B | 6.003 B | 5.839 B | 5.417 B | |
| Goodwill | 12.852 B | 12.920 B | 13.269 B | 13.659 B | 13.608 B | 14.387 B | 14.361 B | 14.397 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 31.947 B | 32.469 B | 32.891 B | 33.603 B | 34.043 B | 35.134 B | 36.669 B | 37.110 B | |
| Total liabilities | 14.308 B | 14.897 B | 14.784 B | 15.375 B | 15.157 B | 15.853 B | 16.743 B | 16.736 B | |
| Total current liabilities | 3.551 B | 3.804 B | 4.082 B | 4.562 B | 4.579 B | 4.932 B | 4.917 B | 5.576 B | |
| Accounts Payable | 803.000 M | 862.000 M | 868.000 M | 899.000 M | 929.000 M | 942.000 M | 921.000 M | 906.000 M | |
| Other liabilities | 1.565 B | 1.687 B | 1.637 B | 1.524 B | 1.458 B | 1.578 B | 1.536 B | 1.434 B | |
| Current long term debt | 20.000 M | 20.000 M | 510.000 M | 559.000 M | 513.000 M | 531.000 M | 1.085 B | 1.580 B | |
| Long term debt | 8.564 B | 8.915 B | 8.495 B | 8.494 B | 8.386 B | 8.571 B | 9.534 B | 8.991 B | |
| Other liabilities | 1.565 B | 1.687 B | 1.637 B | 1.524 B | 1.458 B | 1.578 B | 1.536 B | 1.434 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 259.000 M | 243.000 M | 248.000 M | 242.000 M | 238.000 M | |
| Total Shareholder equity | 17.641 B | 17.574 B | 18.109 B | 18.226 B | 18.885 B | 19.281 B | 19.925 B | 20.372 B | |
| Common stock | 1.432 B | 1.433 B | 1.436 B | 1.446 B | 1.465 B | 1.466 B | 1.468 B | 1.471 B | |
| Retained earnings | -876.000 M | -750.000 M | -450.000 M | -189.000 M | 315.000 M | 819.000 M | 1.314 B | 1.639 B |